About
NeuroPace, Inc. is a medical device company based in Mountain View, California, focused on innovative therapies for neurological disorders, particularly epilepsy. The company aims to improve the lives of individuals with epilepsy by reducing or eliminating seizures through advanced technology. The flagship product, the RNS® System, is the first commercially available brain-responsive neurostimulation platform. This closed-loop system monitors brain activity in real time and delivers personalized electrical stimulation to prevent seizures before they occur. It is designed for patients with drug-resistant focal epilepsy. Additionally, NeuroPace offers the NeuroPace Cloud platform, which enables remote monitoring and data analysis to optimize therapy settings and support clinical decision-making. NeuroPace is committed to research and development, manufacturing, clinical support, and targeted sales efforts. The company has experienced significant financial growth, reporting $65.4 million in revenue in 2023, driven by the adoption of the RNS System. NeuroPace also engages in research collaborations, including a notable NIH grant to study the RNS System's application in treating Lennox-Gastaut Syndrome.
Technologies
Keywords
Company Information
- Employees190
- Founded1999
- Annual Revenue$84306000
- Total Funding$428185618
Location
455 North Bernardo Avenue, Mountain View, California, United States, 94043
